Abiomed Inc (ABMD.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|50||2005||Chairman of the Board, President, Chief Executive Officer|
|51||2015||Chief Financial Officer, Vice President, Treasurer|
|55||2007||Chief Operating Officer|
|65||2015||Senior Vice President, Global Quality, Regulatory and Clinical Operations|
|44||2014||Vice President, General Manager - Global Marketing|
- BRIEF-Abiomed Q1 gaap earnings per share $0.82
- BRIEF-Abiomed reports Q1 EPS $0.82
- BRIEF-New study with Abiomed's Impella 2.5 Heart Pump demonstrates potential survival with pre-PCI insertion in heart attacks with the left main coronary artery
- BRIEF-Abiomed says enrolled first patient in FDA approved prospective feasibility study
- BRIEF-Abiomed Q4 gaap earnings per share $0.33